All Posts

The Canadian cannabis industry, since its federal legalization, has entered a new phase of maturation defined by heightened regulatory scrutiny and an increasing focus on consumer safety. For cannabis licence holders, particularly small and medium-sized enterprises (SMEs), navigating the complex requirements for post-market surveillance and adverse event (AE) reporting presents a significant challenge. Failure to comply with Health Canada's regulations not only exposes busine